TOKYO, Jan 7 (Reuters) - Japan's Hisamitsu Pharmaceutical is planning to take the company private in a management buyout for nearly 400 billion yen ($2.55 billion), it said in a filing late on Tuesday ...
Hisamitsu Pharmaceutical Co.’s ¥457 billion ($2.9 billion) plan to go private is being seen as a prime example of a flight from public markets among Japan’s drugmakers, with analysts expecting more to ...
TipRanks on MSN
Hisamitsu withdraws earnings forecast amid MBO-linked tender offer and planned delisting
An update from Hisamitsu Pharmaceutical Co ( ($JP:4530) ) is now available. Hisamitsu Pharmaceutical has withdrawn its consolidated earnings ...
Hisamitsu Pharmaceutical Co. is set to climb to its daily trading limit for a second day after the Japanese maker of pain-relief patches announced it would go private in a management buyout valued at ...
Hisamitsu Pharmaceutical Co. Inc. President and CEO Kazuhide Nakatomi is leading a management buyout to take the company private, citing mounting drug pricing pressures and tougher listing ...
TipRanks on MSN
Hisamitsu Pharmaceutical scraps year-end dividend as board backs privatization tender offer
Hisamitsu Pharmaceutical Co ( ($JP:4530) ) just unveiled an update. Hisamitsu Pharmaceutical has revised its dividend forecast for the fiscal year ...
Hisamitsu Pharmaceutical Co. Inc. (4530.TO) Japan Nine Months Ended November 30 GROUP 2025 2024 Revenue Y114.51 bln Y111.25 bln Operating Profit Y12.61 bln Y13.22 bln Pretax Profit Y16.63 bln Y16.47 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results